Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the “THERAPY”phase 1-2 trial
2015 · Oncotarget · 83 citations
https://doi.org/10.18632/oncotarget.3473